132 related articles for article (PubMed ID: 8577931)
21. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
22. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas.
Hannibal J; Fahrenkrug J
Cell Tissue Res; 2000 Jan; 299(1):59-70. PubMed ID: 10654070
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.
Elsås T; Uddman R; Sundler F
Graefes Arch Clin Exp Ophthalmol; 1996 Sep; 234(9):573-80. PubMed ID: 8880156
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus.
Hannibal J; Mikkelsen JD; Clausen H; Holst JJ; Wulff BS; Fahrenkrug J
Regul Pept; 1995 Jan; 55(2):133-48. PubMed ID: 7754101
[TBL] [Abstract][Full Text] [Related]
27. Adrenal pheochromocytoma PC12h cells respond to pituitary adenylate cyclase activating polypeptide.
Watanabe T; Ohtaki T; Kitada C; Tsuda M; Fujino M
Biochem Biophys Res Commun; 1990 Nov; 173(1):252-8. PubMed ID: 2175177
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.
Kirchgessner AL; Liu MT
Anat Rec; 2001 Jan; 262(1):91-100. PubMed ID: 11146432
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11.
Gourlet P; Vandermeers A; Robberecht P; Deschodt-Lanckman M
Biochem Pharmacol; 1997 Aug; 54(4):509-15. PubMed ID: 9313778
[TBL] [Abstract][Full Text] [Related]
30. Distribution of PACAP (pituitary adenylate cyclase-activating polypeptide)-like and helospectin-like peptides in the teleost gut.
Olsson C; Holmgren S
Cell Tissue Res; 1994 Sep; 277(3):539-47. PubMed ID: 7954690
[TBL] [Abstract][Full Text] [Related]
31. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
32. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
33. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
Ando E; Nokihara K; Naruse S; Wray V
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
[TBL] [Abstract][Full Text] [Related]
34. PACAP (pituitary adenylate cyclase-activating peptide)-like immunoreactivity in the gill arch of the goldfish, Carassius auratus: distribution and comparison with VIP.
de Girolamo P; Arcamone N; Rosica A; Gargiulo G
Cell Tissue Res; 1998 Sep; 293(3):567-71. PubMed ID: 9716747
[TBL] [Abstract][Full Text] [Related]
35. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
[TBL] [Abstract][Full Text] [Related]
36. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence.
Schomerus C; Maronde E; Laedtke E; Korf HW
Cell Tissue Res; 1996 Dec; 286(3):305-13. PubMed ID: 8929333
[TBL] [Abstract][Full Text] [Related]
38. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
39. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells.
Hannibal J; Fahrenkrug J
Regul Pept; 1995 Jan; 55(1):111-5. PubMed ID: 7724826
[TBL] [Abstract][Full Text] [Related]
40. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
